American Journal of Cardiology
Volume 102, Issue 7 , Pages 797-801 , 1 October 2008

Association Between Serum Uric Acid and Perioperative and Late Cardiovascular Outcome in Patients With Suspected or Definite Coronary Artery Disease Undergoing Elective Vascular Surgery

  • Martin Dunkelgrun, MD

      Affiliations

    • Department of Vascular Surgery, Erasmus Medical Centre, Rotterdam, the Netherlands
  • ,
  • Gijs M.J.M. Welten, MD

      Affiliations

    • Department of Vascular Surgery, Erasmus Medical Centre, Rotterdam, the Netherlands
  • ,
  • Dustin Goei, MD

      Affiliations

    • Department of Vascular Surgery, Erasmus Medical Centre, Rotterdam, the Netherlands
  • ,
  • Tamara A. Winkel, MD

      Affiliations

    • Department of Vascular Surgery, Erasmus Medical Centre, Rotterdam, the Netherlands
  • ,
  • Olaf Schouten, MD

      Affiliations

    • Department of Vascular Surgery, Erasmus Medical Centre, Rotterdam, the Netherlands
  • ,
  • Ron T. van Domburg, PhD

      Affiliations

    • Department of Clinical Epidemiology, Erasmus Medical Centre, Rotterdam, the Netherlands
  • ,
  • Yvette R.B.M. van Gestel, MSc

      Affiliations

    • Department of Clinical Epidemiology, Erasmus Medical Centre, Rotterdam, the Netherlands
  • ,
  • Willem-Jan Flu, MD

      Affiliations

    • Department of Cardiology, Erasmus Medical Centre, Rotterdam, the Netherlands
  • ,
  • Sanne E. Hoeks, MSc

      Affiliations

    • Department of Clinical Epidemiology, Erasmus Medical Centre, Rotterdam, the Netherlands
  • ,
  • Jeroen J. Bax, MD

      Affiliations

    • Department of Cardiology, Leiden University Medical Centre, Leiden, the Netherlands
  • ,
  • Don Poldermans, MD

      Affiliations

    • Department of Anesthesiology, Erasmus Medical Centre, Rotterdam, the Netherlands
    • Corresponding Author InformationCorresponding author: Tel: +31107034613; fax: +31107034957

Received 5 February 2007 ,Revised 14 May 2007 ,Accepted 14 May 2007.

References 

  1. Garcia Puig J, Mateos FA. Clinical and biochemical aspects of uric acid overproduction. Pharm World Schi. 1994;16:40–54
  2. Mikkelsen WM, Dodge HJ, Valkenburg H. The distribution of serum uric acid values in a population unselected as to gout of hyperuricemia: Tecumseh, Michigan 1959–1960. Am J Med. 1965;242–251
  3. Levine W, Dyer AR, Shekelle RB, Schoenberger JA, Stamler J. Serum uric acid and 11.5-year mortality of middle-aged women: findings of the Chicago Heart Association Detection Project in Industry. J Clin Epidemiol. 1989;42:257–267
  4. Alderman MH, Cohen H, Madhavan S, Kivlighn S. Serum uric acid and cardiovascular events in successfully treated hypertensive patients. Hypertension. 1999;34:144–150
  5. Freedman DS, Williamson DF, Gunter EW, Byers T. Relation of serum uric acid to mortality and ischemic heart disease (The NHANES I Epidemiologic Follow-up Study). Am J Epidemiol. 1995;141:637–644
  6. Niskanen LK, Laaksonen DE, Nyyssönen K, Alfthan G, Lakka HM, Lakka TA, et al. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med. 2004;164:1546–1551
  7. Wannamethee SG, Shaper AG, Whincup PH. Serum urate and the risk of major coronary heart disease events. Heart. 1997;78:147–153
  8. Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med. 1999;131:7–13
  9. Froissart M, Rossert J, Jacquot C, Paillard M, Houillier P. Predictive performance of the modification of diet in renal disease and Cockroft-Gault equations for estimating renal function. J Am Soc Nephrol. 2005;16:763–773
  10. Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF, et al Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999;100:1043–1049
  11. Tuttle KR, Short RA, Johnson RJ. Sex differences in uric acid and risk factors for coronary artery disease. Am J Cardiol. 2001;87:1411–1414
  12. Vigna GB, Bolzan M, Romagnoni F, Valerio G, Vitale E, Zuliani G, et al. Lipids and other risk factors selected by discriminant analysis in symptomatic patients with supra-aortic and peripheral atherosclerosis. Circulation. 1992;85:2205–2211
  13. Saggiani F, Pilati S, Targher G, Branzi P, Muggeo M, Bonora E. Serum uric acid and related factors in 500 hospitalized subjects. Metabolism. 1996;45:1557–1561
  14. Brand FN, McGee DL, Kannel WB, Stokes J, Castelli WP. Hyperuricemia as a risk factor of coronary heart disease: The Framingham Study. Am J Epidemiol. 1985;121:11–18
  15. Klein R, Klein BE, Cornoni J, Maready J, Cassel JC, Tyroler HA. Serum uric acid, Georgia. Arch Intern Med. 1973;132:401–410
  16. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971–1992 (National Health and Nutrition Examination Survey). JAMA. 2000;283:2404–2410
  17. Strasak AM, Kelleher CC, Brant LJ, Rapp K, Ruttmann E, Concin H, et al. Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: A prospective 21-year follow-up study. Int J Cardiol. 2008;125:232–239
  18. Suarna C, Dean RT, May J, Stocker R. Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of α-tocopherol and ascorbate. Arterioscler Thromb Vasc Biol. 1995;15:1616–1624
  19. Visy JM, Le Coz P, Chadefaux B, Fressinaud C, Woimant F, Marquet J, et al. Homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency revealed by stroke in adult siblings. Neurology. 1991;41:1313–1315
  20. De Scheerder IK, van de Kraay AM, Lamers JM, Koster JF, de Jong JW, Serruys PW. Myocardial malondialdehyde and uric acid release after short-lasting coronary occlusions during angioplasty: potential mechanisms for free radical generation. Am J Cardiol. 1991;68:392–395
  21. Kanellis J, Kang DH. Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease. Semin Nephrol. 2005;39–42

 Dr. Dunkelgrun is supported by unrestricted research grant #2003B143 from the Netherlands Heart Foundation. Dr. Schouten is supported by an unrestricted research grant (ZonMW) from the Netherlands Organization of Health Research and Development, The Hague, the Netherlands. S. Hoeks, MSc, Y. van Gestel, MSc, and Dr. Flu are supported by an unrestricted research grant from Lijf and Leven Foundation, Rotterdam, the Netherlands.

PII: S0002-9149(08)00898-9

doi: 10.1016/j.amjcard.2008.05.019

American Journal of Cardiology
Volume 102, Issue 7 , Pages 797-801 , 1 October 2008